AR040039A1 - 1,2-diaza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumoral e intermediarios para su preparacion - Google Patents
1,2-diaza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumoral e intermediarios para su preparacionInfo
- Publication number
- AR040039A1 AR040039A1 ARP030101803A ARP030101803A AR040039A1 AR 040039 A1 AR040039 A1 AR 040039A1 AR P030101803 A ARP030101803 A AR P030101803A AR P030101803 A ARP030101803 A AR P030101803A AR 040039 A1 AR040039 A1 AR 040039A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- amino
- optionally substituted
- alkanoyl
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de 1,2-diaza-dibenzoazuleno, sus sales y solvatos farmacéuticamente aceptables, procedimientos e intermediarios para su preparación, como así también sus acciones antiinflamatorias, especialmente a la inhibición de la producción del factor-? de necrosis tumoral (TNF-a), y la inhibición de la producción de interleucina-1 (IL-1) como así también a su acción analgésica. Reivindicación 1: Compuestos de fórmula (1) caracterizados porque X puede ser CH o un heteroátomo tal como O, S, S(=O), S(=O)2, o NRa, donde Ra es H o un grupo protector; Y y Z independientemente entre sí denotan uno o más sustituyentes idénticos o diferentes unidos a cualquier átomo de C disponible, y pueden ser halógeno, C1-4 alquilo, C2-4 alquenilo, C2-4 alquinilo, halo-C1-4 alquilo, hidroxi, C1-4 alcoxi, trifluorometoxi, C1-4 alcanoilo, amino, amino-C1-4 alquilo, N-(C1-4-alquilo)amino, N,N-di(C1-4-alquilo)amino, tiol, C1-4 alquiltio, sulfonilo, C1-4 alquilosulfonilo, sulfinilo, C1-4 alquilosulfinilo, carboxi, C1-4 alcoxicarbonilo, ciano, nitro; R1 puede ser halógeno, un heteroarilo o heterociclo opcionalmente sustituido, hidroxi, C1-7 alcoxi, ariloxi, amino, N-(C1-7) alquiloamino, N,N-di( C1-7-alquilo)amino, (C1-7-alquilo)amino, amino-C1-7 alcoxi, C1-7 alcanoilo, aroilo, C1-7 alcanoiloxi, carboxi, C1-7 alquiloxicarbonilo o ariloxicarbonilo opcionalmente sustituido, carbamoilo, N-(C1-7-alquilo) carbamoilo, N,N-di (C1-7-alquilo)carbamoilo, ciano, nitro, o un sustituyente de fórmula (2) donde R3 y R4 simultánea o independientemente entre sí pueden ser H, C1-4 alquilo, arilo o junto con N tienen el significado de un heterociclo o heteroarilo opcionalmente sustituido; m y n representan un entero de 0 a 3; Q1 y Q2 representan, independientemente entre sí, O, S o grupos de fórmulas (3) donde los sustituyentes Y1 e Y2 independientemente entre sí pueden ser H, halógeno, C1-4 alquilo o arilo opcionalmente sustituidos, hidroxi, C1-4 alcoxi, C1-4 alcanoilo, tiol, C1-4 alquiltio, sulfonilo, C1-4 alquilosulfonilo, sulfinilo, C1-4 alquilosulfinilo, ciano, nitro o juntos forman un grupo carbonilo o imino; R2 significa H, C1-7 alquilo o arilo opcionalmente sustituido o un grupo protector: formilo, C1-7 alcanoilo, C1-7 alcoxicarbonilo, ariloalquiloxicarbonilo, aroilo, ariloalquilo, C1-7 alquilosililo; como así también sus sales farmacológicamente aceptables y solvatos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20020452A HRP20020452A2 (en) | 2002-05-23 | 2002-05-23 | 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040039A1 true AR040039A1 (es) | 2005-03-09 |
Family
ID=29559973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101803A AR040039A1 (es) | 2002-05-23 | 2003-05-23 | 1,2-diaza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumoral e intermediarios para su preparacion |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7550498B2 (es) |
| EP (1) | EP1587807B1 (es) |
| JP (1) | JP2006500322A (es) |
| CN (1) | CN1671712A (es) |
| AR (1) | AR040039A1 (es) |
| AT (1) | ATE398621T1 (es) |
| AU (1) | AU2003232368A1 (es) |
| CA (1) | CA2487015A1 (es) |
| DE (1) | DE60321724D1 (es) |
| ES (1) | ES2306888T3 (es) |
| HR (1) | HRP20020452A2 (es) |
| IS (1) | IS7565A (es) |
| PL (1) | PL374341A1 (es) |
| RS (1) | RS100204A (es) |
| WO (1) | WO2003099822A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ545836A (en) | 2003-09-17 | 2009-09-25 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as serotonin receptor modulators |
| HRP20030956A2 (en) * | 2003-11-21 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU |
| EP2308866A1 (de) | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide |
| AR086992A1 (es) | 2011-06-20 | 2014-02-05 | Bayer Ip Gmbh | Tienilpiri(mi)dinilpirazoles |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH532038A (de) | 1970-05-25 | 1972-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Cycloheptenderivaten |
| US3859439A (en) | 1970-05-26 | 1975-01-07 | Ciba Geigy Corp | 2,3-dihydro-5 -trifluoromethyl-1h-dibenzo(2,3:6,7) thiepino (4,5-c) pyrroles as cns-depressants |
| US3711489A (en) | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
| CA967573A (en) | 1972-12-22 | 1975-05-13 | Joseph G. Lombardino | Tetracyclic anti-inflammatory agents |
| US4112110A (en) | 1974-02-22 | 1978-09-05 | Ciba-Geigy Corporation | Oxygenated azatetracyclic compounds |
| US4271179A (en) | 1976-05-24 | 1981-06-02 | Akzona Incorporated | 1,2,3,3a,8,12b-Hexahydro-dibenzo[1,2;5,6]cyclohepta[3,4-C]pyrroles and pharmaceutical use thereof |
| US4198421A (en) | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
| US4267184A (en) | 1979-02-08 | 1981-05-12 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-2-(substituted-thio)pyrroles and their corresponding sulfoxides and sulfones |
| US4267190A (en) | 1980-04-18 | 1981-05-12 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-α,α-bis(polyfluoromethyl)-1H-pyrrole-2-methanethiols |
| FR2504140A1 (fr) | 1981-04-16 | 1982-10-22 | Centre Nat Rech Scient | Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant |
| FI841399A (fi) | 1983-04-12 | 1984-10-13 | Ciba Geigy Ag | Polycykliska karboxylsyrafoereningar, foerfarande foer deras framstaellning och dessa karboxylsyrafoereningar innehaollande preparat samt deras anvaendning. |
| IE62754B1 (en) | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants |
| US5166214A (en) | 1988-12-05 | 1992-11-24 | Du Pont Merck Pharmaceutical Company | Use of imidazoles for the treatment of atherosclerosis |
| CA2003283A1 (en) | 1988-12-05 | 1990-06-05 | C. Anne Higley | Imidazoles for the treatment of atherosclerosis |
| PL337027A1 (en) | 1997-05-26 | 2000-07-31 | Akzo Nobel Nv | Salts of aromatic sulphonic acids |
| HRP20000310A2 (en) | 2000-05-17 | 2002-02-28 | Pliva Farmaceutska Ind Dioniko | New dibenzoazulene compounds as tumor necrosis factor inhibitors |
| HRP20020305A8 (en) * | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| HRP20020440B1 (en) | 2002-05-21 | 2008-02-29 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
-
2002
- 2002-05-23 HR HR20020452A patent/HRP20020452A2/hr not_active Application Discontinuation
-
2003
- 2003-05-20 US US10/515,709 patent/US7550498B2/en not_active Expired - Fee Related
- 2003-05-20 AU AU2003232368A patent/AU2003232368A1/en not_active Abandoned
- 2003-05-20 RS YU100204A patent/RS100204A/sr unknown
- 2003-05-20 WO PCT/HR2003/000022 patent/WO2003099822A2/en active IP Right Grant
- 2003-05-20 EP EP03755234A patent/EP1587807B1/en not_active Expired - Lifetime
- 2003-05-20 DE DE60321724T patent/DE60321724D1/de not_active Expired - Fee Related
- 2003-05-20 AT AT03755234T patent/ATE398621T1/de not_active IP Right Cessation
- 2003-05-20 CA CA002487015A patent/CA2487015A1/en not_active Abandoned
- 2003-05-20 PL PL03374341A patent/PL374341A1/xx not_active Application Discontinuation
- 2003-05-20 ES ES03755234T patent/ES2306888T3/es not_active Expired - Lifetime
- 2003-05-20 CN CNA038167042A patent/CN1671712A/zh active Pending
- 2003-05-20 JP JP2004507479A patent/JP2006500322A/ja active Pending
- 2003-05-23 AR ARP030101803A patent/AR040039A1/es not_active Application Discontinuation
-
2004
- 2004-11-29 IS IS7565A patent/IS7565A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1587807A2 (en) | 2005-10-26 |
| DE60321724D1 (de) | 2008-07-31 |
| EP1587807B1 (en) | 2008-06-18 |
| PL374341A1 (en) | 2005-10-17 |
| AU2003232368A1 (en) | 2003-12-12 |
| HRP20020452A2 (en) | 2004-02-29 |
| US20050209296A1 (en) | 2005-09-22 |
| EP1587807A3 (en) | 2005-11-16 |
| JP2006500322A (ja) | 2006-01-05 |
| IS7565A (is) | 2004-11-29 |
| RS100204A (en) | 2006-10-27 |
| US7550498B2 (en) | 2009-06-23 |
| CA2487015A1 (en) | 2003-12-04 |
| ATE398621T1 (de) | 2008-07-15 |
| AU2003232368A8 (en) | 2003-12-12 |
| WO2003099822A3 (en) | 2005-09-29 |
| ES2306888T3 (es) | 2008-11-16 |
| CN1671712A (zh) | 2005-09-21 |
| WO2003099822A2 (en) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5680435A2 (es) | Derivados de quinazolina inhibidores de tirosina quinasa erbb y egb, su procedimiento de sintesis y composiciones farmaceuticas que los contienen | |
| AR048642A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento | |
| PE20221253A1 (es) | Inhibidores de pequenas moleculas de mutante g12c de kras | |
| AR044909A1 (es) | Derivados de tiazolilpiperidina, procesos para su preparacion, composiciones farmaceuticas que los comprenden y aplicaciones de dichos derivados en el tratamiento de hipertrigliceridemia , hipercolesterolemia y dislipidemia | |
| ATE442356T1 (de) | 1-essigsäureindolderivate mit pgd2- antagonistischer wirkung | |
| DOP2002000349A (es) | Nuevos compuestos antiinflamatorios de bencimidazol | |
| MX2010000658A (es) | Derivados de pirimidina 934. | |
| AR011623A1 (es) | Compuestos de sulfonamidas, procedimiento para prepararlos y composiciones farmaceuticas para potenciar las funciones de los glutamatoreceptores enmamiferos. | |
| EA200870362A1 (ru) | Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида | |
| AR054612A1 (es) | Derivados de espiroquetas y composiciones farmaceuticas para su utilizacion como agente terapeutico para diabetes | |
| CO6251252A2 (es) | Metabolitos de derivados del (tio)-carbamoil-ciclohexano | |
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| AR054484A1 (es) | Derivados de 2-azetidinonas como inhibidores de la absorcion de colesterol | |
| AR049712A1 (es) | DERIVADOS DE PIRIMIDINA COMO INHIBIDORES DE PI3K; MÉTODOS PARA SU PREPARACIoN; COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO CON EFECTO ANTI-PROLIFERATIVO. | |
| AR033379A1 (es) | Compuestos de difenilurea, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR042690A1 (es) | Derivados de pirrolil-tiazol como agonistas inversos de receptores cb1; preparacion de los mismos y composiciones farmaceuticas que los contienen | |
| AR066604A1 (es) | Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente. | |
| AR040086A1 (es) | Derivados de 1-aza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumorale intermediarios para su preparacion | |
| AR029400A1 (es) | Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende | |
| AR068376A1 (es) | Amidas heterociclicas utiles para inhibir la via hedgehog. | |
| RU2010115337A (ru) | Трициклические гетероциклические производные | |
| AR040040A1 (es) | 1,3-diaza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumoral e intermediarios para su preparacion | |
| AR041882A1 (es) | Compuestos de imidazopiridina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR040039A1 (es) | 1,2-diaza-dibenzoazulenos para la inhibicion de la produccion del factor de necrosis tumoral e intermediarios para su preparacion | |
| AR074721A1 (es) | Derivados de 1,3 tiazol inhibidores de adn girasa y/o topoisomerasa iv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |